These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38722986)

  • 21. Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations.
    Sherwat A; Brooks JT; Birnkrant D; Kim P
    N Engl J Med; 2022 Aug; 387(7):579-581. PubMed ID: 35921403
    [No Abstract]   [Full Text] [Related]  

  • 22. Ocular manifestations of Monkeypox virus (MPXV) infection with viral persistence in ocular samples: A case series.
    Finamor LPS; Mendes-Correa MC; Rinkevicius M; Macedo G; Sabino EC; Villas-Boas LS; de Paula AV; de Araujo-Heliodoro RH; da Costa AC; Witkin SS; Santos KLC; Palmeira C; Andrade G; Lucena M; de Freitas Santoro D; da Silva LMP; Muccioli C
    Int J Infect Dis; 2024 Sep; 146():107071. PubMed ID: 38710273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hopes dashed for drug aimed at monkeypox virus spreading in Africa.
    Lenharo M
    Nature; 2024 Aug; 632(8027):965. PubMed ID: 39160392
    [No Abstract]   [Full Text] [Related]  

  • 24. Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study.
    McLean J; Stoeckle K; Huang S; Berardi J; Gray B; Glesby MJ; Zucker J
    Ann Intern Med; 2023 May; 176(5):642-648. PubMed ID: 37126820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Case of Neonatal Monkeypox Treated With Oral Tecovirimat.
    Castejon-Ramirez S; Pennington J; Beene H; Hysmith N; Ost S
    Pediatrics; 2024 Jan; 153(1):. PubMed ID: 38148743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome.
    Viguier C; de Kermel T; Boumaza X; Benmedjahed NS; Izopet J; Pasquier C; Delobel P; Mansuy JM; Martin-Blondel G
    Int J Infect Dis; 2022 Dec; 125():135-137. PubMed ID: 36397606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features and management of human monkeypox: a retrospective observational study in the UK.
    Adler H; Gould S; Hine P; Snell LB; Wong W; Houlihan CF; Osborne JC; Rampling T; Beadsworth MB; Duncan CJ; Dunning J; Fletcher TE; Hunter ER; Jacobs M; Khoo SH; Newsholme W; Porter D; Porter RJ; Ratcliffe L; Schmid ML; Semple MG; Tunbridge AJ; Wingfield T; Price NM;
    Lancet Infect Dis; 2022 Aug; 22(8):1153-1162. PubMed ID: 35623380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
    Russo AT; Grosenbach DW; Honeychurch KM; Long PG; Hruby DE
    Expert Rev Anti Infect Ther; 2023 Mar; 21(3):235-242. PubMed ID: 36728515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
    Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous tecovirimat treatment of oral monkeypox lesions in a patient with HIV-1.
    Chen WH; Axell-House DB
    J Med Virol; 2023 Sep; 95(9):e29078. PubMed ID: 37665172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying potential monkeypox virus inhibitors: an
    Ashley CN; Broni E; Wood CM; Okuneye T; Ojukwu MT; Dong Q; Gallagher C; Miller WA
    Front Cell Infect Microbiol; 2024; 14():1351737. PubMed ID: 38500508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.
    Fink DL; Callaby H; Luintel A; Beynon W; Bond H; Lim EY; Gkrania-Klotsas E; Heskin J; Bracchi M; Rathish B; Milligan I; O'Hara G; Rimmer S; Peters JR; Payne L; Mody N; Hodgson B; Lewthwaite P; Lester R; Woolley SD; Sturdy A; Whittington A; Johnson L; Jacobs N; Quartey J; Ai Payne B; Crowe S; Elliott IA; Harrison T; Cole J; Beard K; Cusack TP; Jones I; Banerjee R; Rampling T; ; Dunning J
    Lancet Infect Dis; 2023 May; 23(5):589-597. PubMed ID: 36566771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox.
    Mazzotta V; Cozzi-Lepri A; Lanini S; Mondi A; Carletti F; Tavelli A; Gagliardini R; Vita S; Pinnetti C; Aguglia C; Colavita F; Faccendini P; Matusali G; Faraglia F; Beccacece A; Paulicelli J; Girardi E; Nicastri E; Vaia F; Maggi F; Antinori A
    J Med Virol; 2023 Jun; 95(6):e28868. PubMed ID: 37306318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supervised screening of Tecovirimat-like compounds as potential inhibitors for the monkeypox virus E8L protein.
    Mehmood A; Nawab S; Jia G; Kaushik AC; Wei DQ
    J Biomol Struct Dyn; 2024 Sep; 42(15):8100-8113. PubMed ID: 37561169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat.
    Nunes DDS; Higa LM; Oliveira RL; da Costa LC; Bomfim LM; Gonçalves CCA; Mariani D; Hruby DE; Voloch CM; Castiñeiras TMPP; Tanuri A; Damaso CR
    Mem Inst Oswaldo Cruz; 2023; 118():e230056. PubMed ID: 37436275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on monkeypox virus infection: Focusing current treatment and prevention approaches.
    Dhapola R; Kumari S; Sharma P; KumarKushawaha P; HariKrishnaReddy D
    Fundam Clin Pharmacol; 2024 Jun; 38(3):465-478. PubMed ID: 38226405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Tecovirimat for the Treatment of Smallpox.
    Grosenbach DW; Honeychurch K; Rose EA; Chinsangaram J; Frimm A; Maiti B; Lovejoy C; Meara I; Long P; Hruby DE
    N Engl J Med; 2018 Jul; 379(1):44-53. PubMed ID: 29972742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monkeypox treatment: Current evidence and future perspectives.
    Khani E; Afsharirad B; Entezari-Maleki T
    J Med Virol; 2023 Jan; 95(1):e28229. PubMed ID: 36253931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection.
    Nguyen BT; Marc A; Suñer C; Marks M; Ubals M; Hernández-Rodríguez Á; Melendez MÁ; ; Hruby DE; Russo AT; Mentré F; Mitjà O; Grosenbach DW; Guedj J
    PLoS Biol; 2023 Dec; 21(12):e3002249. PubMed ID: 38127878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Advances in the Prevention and Management of Monkeypox Viral Infection in Humans.
    Gujjar P; Chaudhay R; Verma I; Bansal N; Gupta S; Bansal S
    Curr Drug Targets; 2023; 24(13):1032-1045. PubMed ID: 37842888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.